Target intelligence / Profile preview

Nucleoporin 50kDa pseudogene (None (no standard abbreviation; not a functional protein target))

Target: None (no standard abbreviation; not a functional protein target)
Molecular classification: Pseudogene

Overview

**Nucleoporin 50kDa pseudogene (ENSG00000214132) is a processed pseudogene related to the functional NUP50 gene.** Unlike its functional counterpart, this pseudogene does not produce a protein product and does not participate in the biological functions or nuclear pore complex assembly associated with nucleoporin 50 kDa (Nup50). As a pseudogene, it lacks therapeutic relevance and is not considered a viable drug target or receptor. Pseudogenes may have regulatory or evolutionary significance, but ENSG00000214132 itself has no established molecular function, clinical significance, or disease association in the current scientific and clinical literature

Other names: Nucleoporin 50kDa pseudogenePseudogene of NUP50 (sometimes referred to as NUP50P, NUP50P3 in certain databases)

Mechanism of action

None (not a druggable entity)

Biological functions

None (pseudogenes do not encode active proteins; no biological function)

Disease associations

None (no known disease association for this pseudogene itself; the functional NUP50 protein has roles in disease, but not pseudogenes)

Safety considerations

None (pseudogenes are not directly associated with therapeutic intervention or safety concerns)

Interacting drugs

None (no drugs target this pseudogene)

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on Nucleoporin 50kDa pseudogene (None (no standard abbreviation; not a functional protein target)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleoporin 50kDa pseudogene (None (no standard abbreviation; not a functional protein target)).

Explore the full profile